Chemical management and risk assessment frameworks rely on regulatory toxicity values, but these are available for only a small fraction of commercialized chemicals due to limited available data. To address this gap, the study aims to expand the coverage of chemicals for which toxicity values can be derived by determining surrogate inhalation route points of departure (PODs) and corresponding toxicity values where regulatory assessments are lacking. In vivo data from the U.S. EPA's Toxicity Value Database were curated and selected, and effect values were adjusted to chronic human equivalent benchmark concentrations (BMCh) using the WHO/IPCS framework. Chemical-specific PODs are crucial for evaluating potential risks and toxicological impacts from chemical exposures, and the statistically derived BMCL or LOAEC/NOAEC are typically used as candidate PODs for toxicity value derivation.
This is a pre-print manuscript pending publication in open access scientific journals.
This document has been developed within the framework of the Global Environment Facility (GEF) project ID: 9771 on Global Best Practices on Emerging Chemical Policy Issues of Concern under the Strategic Approach to International Chemicals Management (SAICM).
